Metastatic colorectal cancer occurs when cancer cells spread from the colon or rectum to distant organs, most commonly the liver and peritoneum (lining of the abdominal cavity). At this advanced stage, patients may experience abdominal pain, swelling, weight loss, jaundice (if the liver is involved), fatigue, and general weakness.
Treatment focuses on controlling disease progression and improving survival and quality of life. Management may include surgery, chemotherapy, targeted therapy, immunotherapy, or a multimodal approach. In selected patients with peritoneal metastasis, advanced treatment options such as CRS (Cytoreductive Surgery) + HIPEC (Hyperthermic Intraperitoneal Chemotherapy) are considered. This specialized procedure aims to remove visible tumors and deliver heated chemotherapy directly into the abdominal cavity to target microscopic disease.
Early detection of metastasis and timely intervention significantly improve outcomes.